PHK
AXDX icon

Point72 Hong Kong’s Accelerate Diagnostics AXDX Stock Holding History

Point72 Hong Kong’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-107
Closed -$6K – 1885
2021
Q3 		$6K Buy
+107
New +$6.98K ﹤0.01% 1822
2021
Q1 		– Sell
-125
Closed -$10K – 1799
2020
Q4 		$10K Buy
125
+69
+123% +$6.18K ﹤0.01% 1537
2020
Q3 		$6K Sell
56
-2
-3% -$278 ﹤0.01% 1041
2020
Q2 		$9K Buy
58
+39
+205% +$3.85K ﹤0.01% 991
2020
Q1 		$2K Buy
+19
New +$2.67K ﹤0.01% 841
2019
Q2 		– Sell
-4
Closed -$1K – 1118
2019
Q1 		$1K Buy
+4
New +$750 ﹤0.01% 928

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Point72 Hong Kong's AXDX Position: Q4 2021 in Review

Point72 Hong Kong sold out of Accelerate Diagnostics (AXDX) in Q4 2021, closing a stake of 107 shares — an estimated $6K sold.

Point72 Hong Kong first reported a position in AXDX in Q1 2019 and held it in 6 quarters. The position peaked at $10K in Q4 2020. 107 funds tracked by Wall St. Rank hold AXDX as of Q4 2021.

  • Point72 Hong Kong reported no remaining Accelerate Diagnostics position as of Q4 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 107 Accelerate Diagnostics shares in Q4 2021, an estimated $6K.
  • Point72 Hong Kong first reported a position in Accelerate Diagnostics in Q1 2019 and held it in 6 quarters.
  • Point72 Hong Kong's Accelerate Diagnostics position peaked at $10K in Q4 2020.
  • 107 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.